Funding
Funding not disclosed
Founders
Product
Problem
Access to semaglutide for research purposes is often hindered by high costs associated with branded formulations and the requirement for prescriptions and insurance. This limits its availability for scientific investigation and exploration of its properties.
Solution
ZempX provides generic semaglutide compounds intended for research applications, offering a more accessible and cost-effective alternative to commercially available branded medications. Each batch undergoes rigorous third-party analytical testing to verify potency, sterility, pH, and endotoxin levels, ensuring adherence to quality standards such as USP 797.1 and USP 85. The platform facilitates direct procurement without the need for a prescription or insurance, streamlining the acquisition process for researchers. ZempX offers semaglutide in 2mg and 5mg vial options, with accompanying bacteriostatic water, and provides expedited shipping for timely delivery.
Target Audience
The primary customers are researchers and scientific institutions requiring semaglutide for laboratory studies and experimental investigations.
Features
- Generic semaglutide compounds supplied for research purposes.
- Third-party analytical testing for potency (±10% of stated concentration), sterility (USP 797.1 compliance), pH, and endotoxin levels (USP 85 compliance) on every batch.
- Available in 2mg and 5mg vial configurations.
- Includes 10ml of bacteriostatic water per vial.
- Direct-to-consumer sales model, bypassing prescription and insurance requirements.
- Expedited shipping options for research material delivery.
- Secure, encrypted payment processing.
- 30-day money-back guarantee on satisfaction.